Market Trends of Breast Implant Industry
Silicone Implant is Expected to Hold a Major Share in the Market Over the Forecast Period
Due to rising demand for silicone implants, the silicone segment is expected to dominate the market over the forecast period. These implants are silicone shells filled with a plastic gel (silicone) that resemble human fat because of viscosity and are used for breast augmentation or reconstruction. Compared to other types of implants, they feel like natural breast tissue, which is the primary reason they are preferred by most people seeking implants compared to different kinds. Silicone breast implants are approved for breast augmentation in women 22 or older and for breast reconstruction in women of any age by the United States Food and Drug Administration.
New technological advancements and improvements in the existing silicone breast implant products for breast augmentation and reconstruction are expected to boost the market's growth. For instance, in July 2023, Sientra launched its high-strength cohesive silicone gel breast implants in Canada. Distributed by Clarion Medical Technologies, Sientra is one of the first new silicone gel breast implant manufacturers to receive approval from Health Canada in nearly two decades.
Additionally, increasing companies' initiatives to expand their product reach across the globe is likely to increase market growth. For instance, in October 2023, GC Aesthetics, specializing in designing, manufacturing, and distributing silicone breast implants, and Bimini Health Tech reported a joint venture named OPALINE Aesthetics. This collaboration aims to enhance patient access to breast implant solutions by merging their respective portfolios. This move is expected to complement Bimini's existing Puregraft portfolio, which is renowned among plastic and reconstructive surgeons.
Thus, due to the high demand for silicone-based breast implants coupled with strategic initiatives such as joint ventures by the market players, the market is expected to grow during the forecast period.
North America is Expected to Dominate the Market Over the Forecast Period
North America holds a significant share of the breast implant market and is expected to show a similar trend over the forecast period. This is mainly due to the high demand for breast augmentation surgeries due to several regional entertainment industries and women's self-awareness. The United States is expected to hold the largest market for breast implants in North America during the forecast period.
The demand for cosmetic surgeries and procedures is notably high among women in the United States, driving market growth. For instance, breast augmentation ranked among the top five cosmetic surgical procedures in 2022, with 255.2 thousand surgeries in the country. Many surgeries took place in-office, followed by hospitals and free-standing surgicenters.
Additionally, the rising prevalence of breast cancer in North America will contribute to market growth. In 2024, the American Cancer Society estimated that 310.7 thousand women and 2.8 thousand men would be diagnosed with breast cancer in the United States, potentially influenced by factors like higher obesity rates and changes in reproductive patterns such as lower fertility rates and delayed childbirth.
Additionally, the rise in product approvals by various regulatory organizations is expected to contribute to the market's growth. For instance, in February 2023, Establishment Labs Holdings Inc. completed the submission of the fourth and final part of its application to the FDA for premarket approval of Motiva Implants in the United States.
Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period.
